Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001213900-25-127129
Filing Date
2025-12-31
Accepted
2025-12-31 16:25:03
Documents
1
Effectiveness Date
2025-12-31
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11818
  Complete submission text file 0001213900-25-127129.txt   13042
Mailing Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

EIN.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-568657 | Film No.: 251617698
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)